Back to Search
Start Over
Carisma Therapeutics announces promising preclinical data on engineered macrophages for treating liver fibrosis at AASLD The Liver Meeting 2024
- Source :
- M2 EquityBites (EQB). November 18, 2024
- Publication Year :
- 2024
-
Abstract
- M2 EQUITYBITES-November 18, 2024-Carisma Therapeutics announces promising preclinical data on engineered macrophages for treating liver fibrosis at AASLD The Liver Meeting 2024 (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Clinical-stage biopharmaceutical company Carisma [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 EquityBites (EQB)
- Publication Type :
- News
- Accession number :
- edsgcl.816472311